Article ID Journal Published Year Pages File Type
8442830 European Journal of Cancer 2014 7 Pages PDF
Abstract
The current 3-day adjuvant BEP regimen was effective and safe for patients with MOGCTs.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
Authors
, , , , , , , , , , ,